Healthcare
M&A Advisory
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
Verastem. United States. Announced Date 11/10/2018. Closed Date 18/10/2018. Deal value: $150m. Registered direct offering of convertible notes. Industry: Verastem is a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients.